The Emergence of Human Metapneumovirus in Bangladesh – A Timely Reminder for Global Preparedness
DOI:
https://doi.org/10.61561/ssbgjms.v6i01.79Keywords:
Human Metapneumovirus (HMPV), Emerging Infectious Diseases, Respiratory Infections, Global Health Surveillance, BangladeshAbstract
Background: The recent detection of Human Metapneumovirus (HMPV) in Bangladesh in January 2025 highlights an emerging infectious disease challenge in South Asia. While HMPV has been known since 2001, its presence in Bangladesh underscores the need for vigilance, especially in regions with vulnerable healthcare systems.
Objective: To explore the clinical and epidemiological implications of HMPV’s emergence in Bangladesh and emphasize the importance of preventive measures, research advancements, and global collaboration.
Methods: A commentary approach was utilized, analyzing available data on HMPV, its clinical presentation, epidemiology, and public health strategies. Insights from regional and global infectious disease responses were synthesized.
Findings: HMPV typically causes mild to moderate respiratory infections but can lead to severe outcomes, particularly in at-risk populations. Its emergence in Bangladesh aligns with broader regional trends, as cases have also been reported in China, Japan, Malaysia, and India. In the absence of a licensed vaccine or antiviral treatment, preventive measures such as mask-wearing, hand hygiene, and community education are critical. Advances in mRNA and live attenuated vaccine technologies provide hope for future prevention.
Conclusion: HMPV's appearance in Bangladesh reminds us of the interconnected nature of global health and the persistent threat posed by emerging respiratory pathogens. To mitigate its impact, strengthening surveillance, enhancing healthcare infrastructure, and fostering international research collaborations are essential. Lessons learned from this event can inform strategies to address future infectious disease challenges, reinforcing the global health community’s resilience.
References
1. Crowe, James E. Jr, MD. Human Metapneumovirus as a Major Cause of Human Respiratory Tract Disease. The Pediatric Infectious Disease Journal 23(11): p S215-S221, November 2004. | DOI: 10.1097/01.inf.0000144668.81573.6d
2. Microbe Notes. (2025). Human metapneumovirus and HMPV Infection Explained. Retrieved from https://microbenotes.com/human-metapneumovirus-hmpv/
3. The Daily Star. HMPV-infected woman with comorbidity dies. URL: https://www.thedailystar.net/news/bangladesh/news/hmpv-infected-woman-comorbidity-dies-3800496. Last accessed: [1-29-2025]
4. Dhanasekaran V, Sullivan S, Edwards KM, Xie R, Khvorov A, Valkenburg SA, Cowling BJ, Barr IG. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nature Communications. 2022 Mar 31;13(1):1721.
5. Howard LM, Edwards KM, Zhu Y, Grijalva CG, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ. Clinical features of human metapneumovirus-associated community-acquired pneumonia hospitalizations. Clinical Infectious Diseases. 2021 Jan 1;72(1):108-17.
6. Centers for Disease Control, Prevention (US), National Center for Infectious Diseases (US). Emerging infectious diseases. Centers for Disease Control and Prevention (CDC); 2010.
7. Weerarathna IN, Doelakeh ES, Kiwanuka L, Kumar P, Arora S. Prophylactic and therapeutic vaccine development: advancements and challenges. Molecular Biomedicine. 2024 Nov 11;5(1):57.
8. Siraj MS, Dewey RS, Hassan AF. The infectious diseases act and resource allocation during the COVID-19 pandemic in Bangladesh. Asian Bioethics Review. 2020 Dec;12(4):491-502.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.